Market revenue in 2021 | USD 152.9 million |
Market revenue in 2028 | USD 184.0 million |
Growth rate | 2.7% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Nucleic Acid Sequence Based Amplification (NASBA) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.65% in 2021. Horizon Databook has segmented the South Africa gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
The increasing number of initiatives by the government as well as key market players is the major contributing factor in propelling the market growth in South Africa. Recently in October 2020, a group led by the African Union Commission including private, public, and non-profit organizations introduced an initiative named Africa Pathogen Genomics Initiative with the funding of USD 100 million.
This is an Africa CDC initiative aimed to expand access to genomic sequencing tools leading to strengthening laboratory network access and public health surveillance across Africa. This initiative is expected to increase revenue generation in the South African market.
Similarly, in December 2017, South African researchers conducted a pilot study as a part of The Southern African Human Genome Programme. This initiative aimed at understanding genetic variation in the South African population. Such initiatives are expected to increase the adoption of gene amplification technologies in the market thereby leading to market growth soon.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into South Africa gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account